6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Heart Disease, Ischemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mosienko, BI | 1 |
| Bogoslovskaia, EN; Boĭtsov, SA; Frolov, AA; Golikov, AP; Luk'ianov, MM; Mikhin, VP; Rudnev, DV; Vesel'eva, NV | 1 |
2 trial(s) available for 6-methyl-2-ethyl-3-hydroxypyridine and Heart Disease, Ischemic
| Article | Year |
|---|---|
[Efficacy of the myocardium cytoprotection in patients with ischemic heart disease during extended operations on abdominal organs].
Topics: Cardiac Output; Cardiotonic Agents; Cytoprotection; Gastrointestinal Neoplasms; Humans; Middle Aged; Myocardial Ischemia; Myocardium; Picolines; Premedication; Time Factors | 2013 |
[Efficacy of cytoprotective agent Mexicor in urgent cardiology].
Topics: Angina, Unstable; Cytoprotection; Drug Therapy, Combination; Echocardiography, Doppler; Heart; Hemodynamics; Humans; Hypertension; Myocardial Contraction; Myocardial Ischemia; Picolines; Vasodilator Agents; Ventricular Function, Left | 2004 |